Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Storheim (NPI 1699744367)

Field	Value
Entity Type	Individual
Organization	John Storheim
Address	2635 N 7th St
City	Grand Junction
State	CO
ZIP	81501
Taxonomy	Anesthesiology Physician
NPI Enumerated	March 15, 2006

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole recorded payer activity: Total Medicare revenue: $1.3M while Total Medicaid revenue: none (no Medicaid billing on file), making the practice effectively single‑payer in the available data and heavily dependent on Medicare cashflow. Analysts should treat Medicaid as absent when modeling payer mix or access implications for this NPI.

Revenue concentration is high: the top three Medicare codes by revenue account for 72.4% of this provider's total Medicare revenue, with J3380 ($433.5K, 32.9%), J0897 ($298.7K, 22.7%), and J3111 ($221.8K, 16.8%) driving the majority of receipts. This level of concentration implies the financial health of the billing profile is closely tied to utilization and reimbursement of a small set of injectable biologics.

The code mix indicates a service line focused on high‑volume biologic drug injections and infusion administration rather than routine anesthesiology CPTs: large revenues are tied to J3380 (vedolizumab), J0897 (denosumab), J3111 (romosozumab), and J1306 (inclisiran), and administration/infusion codes such as 96365 and 96366 also appear in high percentiles. Together these suggest the NPI is billing for drug administration and infusion services as a primary revenue driver rather than procedural anesthesia services.

Competitive standing is mixed but includes notable national prominence for certain drugs: J3380 ranks #37 of 620 providers nationally (94th percentile) and is described as notably above typical national volume, while J0897 ranks #481 of 10057 providers (95th percentile) and is also notably above typical national volume. Other high‑volume administration codes (for example 96365 at the 95th percentile and 96366 at the 96th percentile) reinforce that the provider is a major participant for infusion/administration activity relative to national peers.

Not all high claim activity translates into paid revenue: Q0138 shows 14.3K claims but $0 avg paid/claim and $0 revenue in the file, which materially affects realized income despite high utilization counts. This divergence between claims volume and paid dollars should be investigated further (contracting, denied/reduced payments, or reporting artifact) before assuming those claim counts create revenue.

The presence of oncology/chemotherapy administration codes is notable but not dominant: 96413 accounts for $57.6K (4.4% of Medicare revenue) and ranks #485 of 7514 providers nationally (94th percentile), indicating above‑typical chemotherapy administration volume for a subset of sessions but not a primary revenue source relative to biologic drug injections. This pattern suggests occasional or adjunctive chemotherapy/infusion activity alongside heavier biologic administration.

Provider tenure is long and may reflect an established billing relationship with Medicare: NPI enumerated (registered) 2006-03-15 (~20 years ago). That longevity increases the likelihood that observed high volumes for certain biologics reflect stable service lines or referral relationships rather than a transient billing pattern.

Several additional administration and add‑on infusion codes show high national percentiles (for example 96366 at the 96th percentile, 96365 at the 95th percentile and 96413 at the 94th percentile), reinforcing that the practice’s comparative strength lies in infusion and drug‑administration services. For competitive or network contracting work, payers should view this NPI as a high‑volume administrator of infused/injectable biologics rather than a typical surgical or office‑based anesthesiology biller.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

14 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3380	Injection, vedolizumab, intravenous, 1 mg	25,500	$20	$433.5K
J0897	Injection, denosumab, 1 mg	15,720	$20	$298.7K
J3111	Injection, romosozumab-aqqg, 1 mg	27,720	$10	$221.8K
J1306	Injection, inclisiran, 1 mg	23,270	$10	$209.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	570	$100	$57.6K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,300	$30	$57.5K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	450	$50	$21.5K
96366	The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease.	590	$10	$7.6K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	350	$10	$3.9K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	130	$20	$2.8K

Showing 1–10 of 14

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

John Storheim — 6 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

14 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3380	1	20	7,500	$20	$144.4K
J1306	2	10	10,080	$10	$143.2K
J1745	24	40	3,180	$30	$110.6K
J3111	4	40	9,770	$10	$108.3K
J0897	3	140	2,580	$20	$68.8K
96413	5	140	130	$100	$19.7K
96365	17	170	100	$50	$9.5K
Q0138	5	10	12,750	$1	$5.2K
96415	26	110	80	$20	$2.2K
96366	2	70	90	$20	$2.2K

Showing 1–10 of 14

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Storheim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Robert Rifkin	CO	Hematology & Oncology Physician	$3.3M	$0
Jodie Gallegos	CO	Family Nurse Practitioner	$2.8M	$0
Cary Chisholm	TX	Anatomic Pathology & Clinical Pathology Physician	$2.5M	$24.7K
Joseph Dai	AL	Dermatology Physician	$1.6M	$0
Christopher Erickson	CA	Anatomic Pathology & Clinical Pathology Physician	$1.3M	$4.7K
Navid Moradshahi	CA	Diagnostic Radiology Physician	$1.2M	$0
Stephen Markewich	AK	Pain Medicine Physician	$1.1M	$0
Cesar Guerrero	MS	Dermatology Physician	$596.7K	$46K
Dane Stewart	CO	Ophthalmology Physician	$641.7K	$0
Jonathan Harder	CO	Ophthalmology Physician	$444K	$19.3K

Nearby Providers

Other providers in the same ZIP code as John Storheim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Colorado West Regional Mental Health, Inc.	CO	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$84.2M
Mesa Developmental Services Dba Strive	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$59.6M
Tazco, Inc.	CO	Taxi	$0	$39.7M
Hilltop Health Services Corporation	CO	Adult Day Care Clinic/Center	$0	$27.7M
Hilltop Health Services Corporation	CO	Professional Counselor	$0	$24.2M
Mosaic	CO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$16.3M
Martha Amos	CO	Mental Health Counselor	$0	$14.6M
St. Mary's Hospital And Medical Center, Inc.	CO	General Acute Care Hospital	$0	$14.5M
Colorado West Emergency Physicians, LLC	CO	Emergency Medicine Physician	$0	$10.6M
Mls Senior Care	CO	Homemaker	$0	$9M

John Storheim — Billing Profile & Reimbursement Data

Sign up for John Storheim — Billing Profile & Reimbursement Data policy alerts

John Storheim — Billing Profile & Reimbursement Data

Sign up for John Storheim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References